InsidersTradesSigma
Total declarations
Companies
▲ Purchases (17 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
17
Disclosed sells
3
T+90 hit rate
17%
T+90 mean return
-29.2%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Redmile Group, LLC. Insider active across 15 companies, notably Fate Therapeutics INC. Cumulatively, 77 disclosures have been recorded. Split: 17 buys · 3 sells. Total volume traded: €22.7m. Activity tracked since 2 June 2021. The latest transaction was filed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations77 total
828 shares0Common StockSEC:0001104659-25-031353:0
1,734 shares0Common StockSEC:0001104659-25-000432:0
1,084,936 shares@ US$1.6823.6% of flowCommon StockSEC:0001104659-24-131794:0
30,110 sharesCommon StockSEC:0001104659-24-129070:0
50,000 shares@ US$2.289.0% of flowCommon Shares, par value CHF 0.08 per shareSEC:0001104659-24-128575:0
Ideal exit: 7 Sept 2025 (T+270)
133,371 shares@ US$1.25100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-126421:0
25,352 shares@ US$2.074.1% of flowCommon Shares, par value CHF 0.08 per shareSEC:0001104659-24-126422:0
16,421,788 shares@ US$2.3559.5% of flowCommon StockSEC:0001104659-24-106315:0
1,734 shares0Common StockSEC:0001104659-24-105559:0
400,000 shares@ US$2.8186.9% of flowCommon Shares, par value CHF 0.08 per shareSEC:0001104659-24-077865:0
Ideal exit: 28 Mar 2025 (T+270)
1,734 shares0Common StockSEC:0001104659-24-077493:0
12,879 shares0Common StockSEC:0001104659-24-073005:0
8,820 shares0Common StockSEC:0001104659-24-071871:0
4,425 shares0Common StockSEC:0001104659-24-042087:0
12,464 shares0Common StockSEC:0001104659-24-042085:0
3,125 shares0Common StockSEC:0001104659-24-036336:0
1,017,203 shares@ US$5.7520.1% of flowCommon StockSEC:0001104659-24-034011:0
222,222 shares@ US$4.50100.0% of flowCommon StockSEC:0001104659-24-031215:0
Ideal exit: 26 Nov 2024 (T+270)
113,400 shares0Common StockSEC:0001104659-24-030166:0
492 shares0Common StockSEC:0001104659-24-001044:0
1,655,370 shares@ US$3.7274.9% of flowCommon StockSEC:0001104659-23-130203:0
1,767 shares0Common StockSEC:0001104659-23-127455:0
750,000 shares@ US$4.004.7% of flowCommon StockSEC:0001104659-23-120752:0
Ideal exit: 16 Aug 2024 (T+270)
492 shares0Common StockSEC:0001104659-23-106524:0
864,509 sharesCommon StockSEC:0001104659-23-102920:0
25 of 77 declarations
About Redmile Group, LLC
Redmile Group, LLC is a significant shareholder of FATE THERAPEUTICS INC.
